Urgent

Ketosis-prone (Flatbush) diabetes

Diabetes · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

A form of type 2 diabetes (often in people of African or Hispanic origin) that presents acutely with diabetic ketoacidosis but where beta-cell function later recovers, allowing eventual withdrawal of insulin. Managed acutely as DKA but with a different long-term trajectory.

Red flags

  • Severe acidosis or haemodynamic instability (as any DKA)
  • Recurrent DKA episodes
  • Failure of expected beta-cell recovery (reconsider type 1)

Assessment

Differential diagnosis

  • Type 1 diabetes with autoimmune markers
  • Classic type 2 diabetes with intercurrent illness
  • Latent autoimmune diabetes of adults
  • Pancreatic (secondary) diabetes
  • Euglycaemic DKA (SGLT2 inhibitor)

Investigations

  • Glucose, ketones, blood gas (diagnose DKA)
  • Islet autoantibodies (GAD, IA-2) - typically negative
  • C-peptide (to assess residual beta-cell function, often after recovery)
  • HbA1c
  • Standard DKA monitoring bloods

Management

  • Treat the acute presentation exactly as diabetic ketoacidosis (fluids, fixed-rate insulin, potassium, monitoring)
  • Send autoantibodies and plan C-peptide assessment to characterise the diabetes type
  • Continue insulin initially after resolution
  • Reassess beta-cell function over the following weeks/months
  • In antibody-negative patients with recovering function, cautiously transition toward oral agents under specialist guidance
  • Educate on ketone monitoring and sick-day rules

Drugs & doses

Acute DKA management: IV fluids, fixed-rate insulin infusion, potassium replacement
Basal-bolus insulin after recovery initially
Later transition to oral hypoglycaemics (e.g. metformin) if beta-cell function recovers
Follow standard DKA protocol

Disposition

Admit and treat as DKA; endocrine follow-up to reclassify and adjust therapy.

Complications & pitfalls

  • Recurrent ketoacidosis
  • Misclassification of diabetes type and inappropriate long-term therapy
  • Standard DKA complications

Exam pearls

  • Antibody-negative DKA in an adult of African/Hispanic origin may be ketosis-prone type 2 diabetes - beta-cell function can recover
  • C-peptide measured after recovery helps decide who can come off insulin

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.